Delhi High Court Awards Johnson & Johnson ₹3.34 Crore Compensation in Counterfeit Medical Products Case

The Delhi High Court (‘DHC’), observing that counterfeiting medical products poses great public health risks and amounts to trademark infringement, awarded Johnson & Johnson (‘J&J’) ₹3.34 crore in damages against the defendant. The DHC observed that by selling substandard counterfeit products under J&J’s trademarks, the defendants had misled consumers and damaged J&J’s name.